Risk factors for hepatotoxicity in HIV-1-infected patients receiving ritonavir and saquinavir with or without stavudine

Clinical Infectious Diseases

Volumn 31, Issue 5, 2000, Pages 1234-1239

  Gisolf, E H ^a,c   Dreezen, C ^b   Danner, S A ^a,d   Weel, J L F ^a   Weverling, G J ^a,c   Reiss, P ^c   Duurvoort, M ^c   Krijger, E ^c   Brouwer, E ^c   Visser, G R ^c   Klotz, A ^c   Benschop, C ^c   Wulfert, F ^c   Wolf, F De ^d   Jurriaans, S ^d   Portegies, P ^d   Colebunders, R ^b   Pelgrom, J ^b   Wijnants, H ^b   DE Roo, A ^b   Keersmaekers, K ^b   Vandenbruane, M ^b   Branden, D Van Den ^b   James, T ^b   Wanzeele, F Van ^e   Gucht, B Van Der ^e   Van Der Ende, M E ^f   Nouwen, J ^f   Deenenkamp, R ^f   Van Der Meyden, D ^f   Koopmans, P P ^g   Brinkman, K ^g   Ver Hofstede, H ^g   Zomer, B ^g   Blok, W L ^h   Ruissen, C ^h   Sprenger, H ⁱ   Law, G ⁱ   Meulen, P Vander ⁱ   Veen, C Ten ^j   Juttmann, J R ^k   Heul, C Vander ^k   Santegoets, R ^k   Ven, B Vander ^k   Kate, R W Ten ^l   Schoemaker, M ^l   Kauffmann, R H ^m   Henrichs, J M ^m   Maat, A ^m   Prins, E ^m   Napel, C H H Ten ⁿ   Pogany, K ⁿ   Duyts, T ⁿ   Simons, P ^o   Lacor, P ^o   Waele, A De ^o   Wijngaarden, E Van ^p   Lejeune, M ^p   Nieuwkerk, P ^a   Sprangers, M ^a   Roos, M ^q   Scholte, R ^r   Dijkman, J ^r   Japour, A J ^s   Borst, M J ^t   Leeuwen, E Van ^s   more..

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c Natl AIDS Therapy Evaluation Centre   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h Ziekenhuis Walcheren   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^k CPRLab   (Netherlands)

^l Infection and Immunology   (Netherlands)

^m LEYENBURG HOSPITAL   (Netherlands)

ⁿ MEDISCH SPECTRUM TWENTE   (Netherlands)

^o VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^p UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^q CENTRAL LABORATORY   (Netherlands)

^r Virtual Central Laboratory   (Netherlands)

^s Chemical Design and Synthesis Unit   (Netherlands)

^t Roche Nederland ^*  (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; LIVER ENZYME; RITONAVIR; SAQUINAVIR; STAVUDINE;

ADULT; ANTIGEN DETECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; ALANINE TRANSAMINASE; ANTI-HIV AGENTS; ASPARTATE AMINOTRANSFERASES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B SURFACE ANTIGENS; HIV INFECTIONS; HUMANS; LIVER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; RITONAVIR; SAQUINAVIR; STAVUDINE;

EID: 0034457420     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317449     Document Type: Article

References (23)

1. Treatment of HIV infection: Tolerability of commonly used antiretroviral agents
2. HBV and HCV co-infection predispose for HAART-associated hepatotoxicity
3. Hepatotoxicity after introduction of highly active antiretroviral therapy
4. Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor
5. Severe hepatitis in three AIDS patients treated with indinavir
6. Enhancement of hepatitis C virus replication and liver damage in HIV-co-infected patients on antiretroviral combination therapy
7. Is the combination of hepatitis and indinavir potentially dangerous?
8. Acute clinical hepatitis in an HIV-seropositive hepatitis B carrier receiving protease inhibitor therapy
9. Acute hepatitis in HIV-infected patients during ritonavir treatment
10. Hepatitis C in an urban population infected with the human immunodeficiency virus
11. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
12. Hepatitis C
13. Hepatitis B virus infection
14. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection
15. Undiagnosed hepatitis C infection in hemodialysis patients: Value of HCV RNA and liver enzyme levels
16. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals
17. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C and B virus infection
18. Severe hepatic cytolysis: Incidence and risk factors in patients treated by antiretroviral combinations: Aquitane Cohort, France, 1996-1998
19. Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with protease inhibitors: An immune restoration disease?
20. The effect of treatment intensification in HIV-infection: A study comparing treatment with ritonavir/saquinavir and ritonavir/saquinavir/stavudine
21. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients
22. Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: A case report